NCT07179822

Brief Summary

The purpose of this research study is to examine the effect of a brain stimulation training to improve the function of brain-spinal cord- muscle connections. Because brain-to-muscle pathways are very important in our movement control, restoring function of these pathways may improve movement problems after injuries. Spinal cord injury causes damage to the brain-to-muscle connection. However, when the injury is "incomplete", there is a possibility that some of the brain-to-muscle pathways are still connected and may be trained to improve movement function. For examining brain-to-muscle pathways, investigators use a transcranial magnetic stimulator. Investigators hope that the results of this research study will help us develop new treatments for people who have movement disabilities. This study will require about 42 visits over the first 14 weeks, and another 6 visits over an additional 3 months. Each visit will take about 1 ½ hours.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
17mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Nov 2025Sep 2027

First Submitted

Initial submission to the registry

September 5, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 3, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

1.9 years

First QC Date

September 5, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

Movement DisordersRehabilitation Studies

Outcome Measures

Primary Outcomes (2)

  • Percent change in the size of the Motor Evoked Potential (MEP) from baseline to final conditioning sessions.

    MEP from each session is expressed as the percent of the initial MEP size (average MEP size from the 6 baseline sessions). The final MEP size is the fitted estimate of the MEP size at the end of 24 intervention sessions. MEP size is a measurement of the integrity of the corticospinal tract.

    Baseline (average of 6 sessions over 2 weeks) and final phase (average of sessions 19-24 over weeks 7-8 of intervention)

  • Change in Spinal Cord Independence Measure--version III (SCIM III) score

    To measure basic functional independence, we will use the most recent version of the SCIM (SCIM III), which is self-reported and comprises 19 items in three sub-scales: (1) self-care (6 items, subscore 0-20); (2) respiration and sphincter management (4 items, sub-score 0-40); and (3) mobility (9 items, subscore 0-40). The total score ranges from 0-100. The items are weighted in terms of their presumed clinical relevance. SCIM score will be used for calculation of MCID.

    Baseline (Week 0), mid-intervention (Week 5, after session 12), post-intervention (Week 9, after session 24), and follow-up at 1 month (Week 13) and 3 months (Week 21) post-intervention.

Study Arms (1)

Motor Evoked Potential (MEP) Operant Conditioning

EXPERIMENTAL

This intervention requires 6 baseline visits and 24 intervention visits, each of which is approximately 1.5 hours.

Behavioral: Motor Evoked Potential (MEP) Operant Conditioning

Interventions

Operant conditioning is a method to induce behavioral learning based on the consequence (reward) of the behavior. With operant conditioning of the motor evoked potential (MEP), the neuronal excitability and behavior of the corticospinal pathway that involves production of MEP is targeted and trained (i.e., up-trained with up-conditioning). The individual is rewarded only for changing the target muscle's MEP size without changing background muscle activity. Since MEP size reflects the corticospinal excitability at or just before the time of stimulation, during MEP up-conditioning trials, the individual is urged to increase the corticospinal excitability for the target muscle.

Motor Evoked Potential (MEP) Operant Conditioning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (≥18 yrs old)
  • a history of injury to spinal cord at or above C6
  • neurologically stable (\>1 year post SCI)
  • medical clearance to participate
  • weak wrist extension at least unilaterally
  • expectation that current medication will be maintained without change for at least 3 months.
  • Stable use of anti-spasticity medication (e.g., baclofen, diazepam, tizanidine) is accepted. (Because only neurologically stable subjects will enter this study, medication changes will be unlikely.)
  • In participants with bilateral wrist extension weakness in whom Extensor Carpi Radialis (ECR) MEP can be elicited in both arms, the more severely impaired arm is studied. In participants with unilateral wrist weakness or in participants with bilateral wrist weakness in whom an ECR MEP can be elicited in only one arm, that arm is studied.

You may not qualify if:

  • motoneuron injury
  • unstable medical condition
  • cognitive impairment (because the studied intervention is a learning-based intervention)
  • a history of epileptic seizures
  • a pre-existing or confounding neurological condition (e.g., history of MS, Stroke, Parkinson's disease)
  • metal implants in the cranium
  • implanted biomedical device in or above the chest (e.g., a cardiac pacemaker, cochlear implant)
  • no measurable MEP elicited in the ECR
  • inability to produce any voluntary ECR EMG activity
  • extensive use of functional electrical stimulation to the arm on a daily basis (as it may interfere with or augment the effects of MEP conditioning itself)
  • pregnancy (due to changes in posture and potential medical instability)
  • inability or unwillingness of subject or legal guardian/representative to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29407, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesDiseaseMovement Disorders

Interventions

Evoked Potentials, Motor

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Evoked PotentialsCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Aiko Thompson, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Occupational Therapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor-Faculty

Study Record Dates

First Submitted

September 5, 2025

First Posted

September 18, 2025

Study Start

November 3, 2025

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations